These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 38795518

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S, Khan IU, Bajda M, Ashraf M, Qurat-Ul-Ain, Shaukat A, Rehman TU, Mutahir S, Hussain S, Mustafa G, Yar M.
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis, Characterization, and Inhibition Study of Novel Substituted Phenylureido Sulfaguanidine Derivatives as α-Glycosidase and Cholinesterase Inhibitors.
    Akocak S, Taslimi P, Lolak N, Işık M, Durgun M, Budak Y, Türkeş C, Gülçin İ, Beydemir Ş.
    Chem Biodivers; 2021 Apr; 18(4):e2000958. PubMed ID: 33620128
    [Abstract] [Full Text] [Related]

  • 6. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Li Y, Zhang JH, Xie HX, Ge YX, Wang KM, Song ZL, Zhu KK, Zhang J, Jiang CS.
    Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Probing benzenesulfonamide-thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase II.
    Gamal MA, Fahim SH, Giovannuzzi S, Fouad MA, Bonardi A, Gratteri P, Supuran CT, Hassan GS.
    Eur J Med Chem; 2024 May 05; 271():116434. PubMed ID: 38653067
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Exploring the Dual Inhibitory Activity of Novel Anthranilic Acid Derivatives towards α-Glucosidase and Glycogen Phosphorylase Antidiabetic Targets: Design, In Vitro Enzyme Assay, and Docking Studies.
    Ihmaid S.
    Molecules; 2018 May 29; 23(6):. PubMed ID: 29844263
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, in vitro Α-Glucosidase, and acetylcholinesterase inhibitory activities of novel Indol-Fused Pyrano[2,3-D]Pyrimidine compounds.
    Nguyen HT, Tuan AN, Thi TAD, Van KT, Le-Nhat-Thuy G, Thi PH, Thi QGN, Thi CB, Quang HT, Van Nguyen T.
    Bioorg Med Chem Lett; 2024 Jan 15; 98():129566. PubMed ID: 38008338
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, molecular modeling, in vitro evaluation of novel piperidine-containing hydrazone derivatives as cholinesterase inhibitors.
    Tok F, Baltaş N, Abas Bİ, Tatar Yılmaz G, Kaya S, Koçyiğit-Kaymakçıoğlu B, Çevik Ö.
    Drug Dev Res; 2024 Aug 15; 85(5):e22240. PubMed ID: 39105636
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Search for new multi-target compounds against Alzheimer's disease among histamine H3 receptor ligands.
    Bajda M, Łażewska D, Godyń J, Zaręba P, Kuder K, Hagenow S, Łątka K, Stawarska E, Stark H, Kieć-Kononowicz K, Malawska B.
    Eur J Med Chem; 2020 Jan 01; 185():111785. PubMed ID: 31669851
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and docking calculations of tetrafluoronaphthalene derivatives and their inhibition profiles against some metabolic enzymes.
    Erdoğan M, Taslimi P, Tuzun B.
    Arch Pharm (Weinheim); 2021 Jun 01; 354(6):e2000409. PubMed ID: 33666284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.